Pharmafile Logo

New syndicated report – Living with Ulcerative Colitis 2024

- PMLiVE

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC.

The report covers the 4EU+UK (France, Germany, Italy, Spain and UK) and Japan with a sample of 278 patients who suffer from UC. The methodology consists of 30-minute quantitative online interviews and 40-minute qualitative tele-web interviews (including pre-task exercises).

Find out more here. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

A Bitter Pill?

The ideal route of admin isn’t clear cut in the global marketplace

Understanding the chronic disease patient journey in emerging markets

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these…

Infographic: Keeping tracking on track

Our best practice approach to tracking studies.

Telehealth Research

The remote exchange of data between patients and their clinician

Case Study: Understanding the patient journey and addiction treatment pathways

Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and…

Research Partnership has published a new Living with Chronic Pain market report for 2016

Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients…

Nutraceuticals: Rich in Potential

Published in eyeforpharma October 2016 by Marc Yates

Case Study: Qualitative research with payers in low and middle income countries

Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in…